This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract, valued at $11,047.00, is for a one-year preventative maintenance agreement covering the EZ1 and EZ2 Connect sample prep instruments from August 16, 2024 to August 15, 2025. Qiagen is an experienced federal contractor, providing a range of sample preparation and molecular diagnostics products...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
This is a federal contract award (75N90025P00400) issued by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic and life sciences products. The contract, valued at $30,071.70, is for a 12-month period of performance and includes the provision of Qiagen's QIAGILITY and QIASYMPHONY SP instruments and associated maintenance services. The contract is not associated with a set-aside program. Qiagen has previously been...
This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,325 firm fixed price purchase order to Qiagen, LLC for preventative maintenance services on two systems, the EZ1 Advanced XL, L151A1461 and the EZ2 Connect, P0123031L. Qiagen, LLC is a division of Qiagen N.V., located in Bethesda, Maryland. The one-year contract period runs from August 16, 2023 through August 15, 2024 to support the NIH Clinical Center's research and patient care activities....
This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic analysis products. The $389,994.64 contract, which does not have a set-aside designation, is for the delivery of various scientific equipment and consumables to support NIEHS's biomedical research and public health initiatives. Key items included under the contract are DNA/RNA...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for preventative maintenance coverage on Qiagen's EZ2 and QIAcell laboratory equipment, with a firm fixed price of $11,517.91 and a period of performance from November 19, 2024 to November 18, 2025. Qiagen is an experienced federal contractor, having...